Upload
PPT-Figure 2 Figure 2. . Correlation of neutralizing antibody titers measured by plaque reduction

PPT-Figure 2 Figure 2. . Correlation of neutralizing antibody titers measured by plaque reduction

Author : delcy | Published Date : 2023-12-30

Temperton NJ Chan PK Simmons G Zambon MC Tedder RS Takeuchi Y et al Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

titer virus neutralizing antibody virus titer sars pseudotype coronavirus assay microsoft measured titers correlation

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 2 Figure 2. . Correlation of neut..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 2 Figure 2. . Correlation of neutralizing antibody titers measured by plaque reduction: Transcript

Download Document

Here is the link to download the presentation.
"Figure 2 Figure 2. . Correlation of neutralizing antibody titers measured by plaque reduction"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Towards an antibody-based HIV vaccine

Towards an antibody-based HIV vaccine
Figure S1: Phenotypic correlation among frost tolerant traits scored on GWBP (189 lines)

Figure S1: Phenotypic correlation among frost tolerant traits scored on GWBP (189 lines)
Supplemental figure 1 PD-L2 (

Supplemental figure 1 PD-L2 (
Figure 7 Figure 7. A. Pleural fluid cell block from a nonfatal case showing abundant

Figure 7 Figure 7. A. Pleural fluid cell block from a nonfatal case showing abundant
Figure Figure. Seroprevalence of neutralizing antibody (titers >16) to

Figure Figure. Seroprevalence of neutralizing antibody (titers >16) to
Figure 1 Figure 1. Structure of Haemophilus influenzae type b (Hib) simulation

Figure 1 Figure 1. Structure of Haemophilus influenzae type b (Hib) simulation
Figure Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis

Figure Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis
Figure 4 Figure 4. A. Plaque-reduction neutralizing antibody titers (PRNT) according

Figure 4 Figure 4. A. Plaque-reduction neutralizing antibody titers (PRNT) according
Figure 1 Figure 1. Serum antibodies (Abs) in patients infected with influenza A(H7N9)

Figure 1 Figure 1. Serum antibodies (Abs) in patients infected with influenza A(H7N9)
Figure S1. Distribution of SERASCA® test titers per farm (n=65 farms, finishers)

Figure S1. Distribution of SERASCA® test titers per farm (n=65 farms, finishers)
Figure Figure. Flow cytometric analysis of T-cell responses to smallpox antigens

Figure Figure. Flow cytometric analysis of T-cell responses to smallpox antigens
Figure 1 Figure 1. Workflow for typing prn alleles. The allele-specific amplification

Figure 1 Figure 1. Workflow for typing prn alleles. The allele-specific amplification
Figure 2 Figure 2. SARS-CoV-2 S antibody seroprevalence, titers, and vaccine doses of

Figure 2 Figure 2. SARS-CoV-2 S antibody seroprevalence, titers, and vaccine doses of